G209-0075 Screening compound: 4-[2-(4-CHLOROPHENYL)-3,4-DIMETHYL-2H-PYRAZOLO[3,4-D]PYRIDAZIN-7-YL]-N-(4-ETHYLPHENYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXAMIDE

G209-0075 Screening compound: 4-[2-(4-CHLOROPHENYL)-3,4-DIMETHYL-2H-PYRAZOLO[3,4-D]PYRIDAZIN-7-YL]-N-(4-ETHYLPHENYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXAMIDE
G209-0075 Screening compound: 4-[2-(4-CHLOROPHENYL)-3,4-DIMETHYL-2H-PYRAZOLO[3,4-D]PYRIDAZIN-7-YL]-N-(4-ETHYLPHENYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXAMIDE alternative view

Chemical Structure Depiction of ChemDiv screening compound G209-0075
4-[2-(4-CHLOROPHENYL)-3,4-DIMETHYL-2H-PYRAZOLO[3,4-D]PYRIDAZIN-7-YL]-N-(4-ETHYLPHENYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXAMIDE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G209-0075

Molecular Formula

C26H28ClN7O (C26 H28 ClN7 O)

Compound Name

4-[2-(4-CHLOROPHENYL)-3,4-DIMETHYL-2H-PYRAZOLO[3,4-D]PYRIDAZIN-7-YL]-N-(4-ETHYLPHENYL)TETRAHYDRO-1(2H)-PYRAZINECARBOXAMIDE

IUPAC name

n/a

SMILES

CCc(cc1)ccc1NC(N(CC1)CCN1c1nnc(C)c2c(C)n(-c(cc3)ccc3Cl)nc12)=O

InChI

InChI=1S/C26H28ClN7O/c1-4-19-5-9-21(10-6-19)28-26(35)33-15-13-32(14-16-33)25-24-23(17(2)29-30-25)18(3)34(31-24)22-11-7-20(27)8-12-22/h5-12H,4,13-16H2,1-3H3,(H,28,35)

InChI Key

NWBFKLIMERXVBG-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14986279

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

490.01

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

4.963

Distribution Coefficient, logD

4.938

Water Solubility, LogSw

-4.93

Polar Surface Area

65.547

Acid Dissociation Constant (pKa)

13.90

Base Dissociation Constant (pKb)

6.17

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

30.77

G209-0075 in Drug Discovery

Included in Screening Libraries

3D-Biodiversity Library (27607 compounds)

Antiviral HBV Library (10007 compounds)

Antiviral Library (67538 compounds)

Protein-Protein Interaction Library (218420 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Target Identification, Phenotypic Screening library (TIPS) (27612 compounds)

Included in 1.7M Stock Database

Structure:
  • 3D
Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators

References: we are preparing a list of scientific research reports with G209-0075 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G209-0075?
Check Price and Availability of G209-0075, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G209-0075 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G209-0075
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G209-0075
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G209-0075 available by request